Related Experiment Video
Updated: Mar 29, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2
Dong Jiang1, Xiaoming Zheng1, Wei Shan1
1Department of Anatomy, College of Basic Medical Sciences, Liaoning Medical University, No. 40, Section 3, Songpo Road, Linghe District, Jinzhou, 121000, China.
Abstract:
MicroRNAs (miRNAs) are emerging as important epigenetic modulators of multiple target genes, leading to abnormal cellular signaling involving cellular proliferation in cancers. Aberrant miRNA expression has been observed in human chondrosarcoma (CS). The purpose of the present study was to evaluate the expression and molecular mechanisms of Runx2 and miR-30a in human CS tissues and CS cell lines JJ012, SW1353, and L3252. In the present study, we found that the expression of miR-30a was markedly downregulated in CS cell lines and human CS tissues, compared to matched non-tumor-associated tissues. Furthermore, miR-30a expression was inversely proportional to that of Runx2 messenger RNA (mRNA) and protein. Upregulation of miR-30a dramatically reduced the proliferation, colony formation, and cell cycle-related proteins of CS cells. Flow cytometry analysis showed that ectopic expression of miR-30a significantly decreased the percentage of S phase cells and increased the percentage of G1/G0 phase cells. Luciferase reporter assays confirmed that miR-30a binding to the 3'-untranslated region (3'-UTR) region of Runx2 inhibited the expression of Runx2 in cancer cells. Taken together, our results suggest that miR-30a plays an important role to inhibit the proliferation of CS cells and presents a novel mechanism for direct miRNA-mediated suppression of Runx2 in CS. Thus, miR-30a/Runx2 may have an important role in treatment of CS patients.
Insights
MicroRNAs (miRNAs) regulate cell growth. In chondrosarcoma (CS), miR-30a is downregulated and inhibits cancer cell proliferation by targeting Runx2, suggesting a therapeutic role for miR-30a in CS treatment.
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- MicroRNAs (miRNAs) are key epigenetic regulators impacting cellular signaling and proliferation in cancers.
- Altered miRNA expression is implicated in human chondrosarcoma (CS) pathogenesis.
Purpose of the Study:
- To investigate the expression patterns and molecular mechanisms of miR-30a and Runx2 in human chondrosarcoma.
- To elucidate the functional role of miR-30a in CS cell proliferation and its regulatory relationship with Runx2.
Main Methods:
- Quantitative analysis of miR-30a and Runx2 expression in CS tissues and cell lines.
- Cell proliferation, colony formation, and cell cycle assays following miR-30a modulation.
- Luciferase reporter assays to confirm direct interaction between miR-30a and Runx2 mRNA.
Main Results:
- miR-30a expression was significantly downregulated in CS tissues and cell lines.
- miR-30a expression inversely correlated with Runx2 mRNA and protein levels.
- Upregulation of miR-30a suppressed CS cell proliferation, colony formation, and induced G1/G0 cell cycle arrest.
- miR-30a directly targets the 3'-UTR of Runx2, inhibiting its expression.
Conclusions:
- miR-30a functions as a tumor suppressor in chondrosarcoma by inhibiting cell proliferation.
- The miR-30a/Runx2 axis represents a novel mechanism for miRNA-mediated gene suppression in CS.
- Targeting the miR-30a/Runx2 pathway holds potential for therapeutic strategies in chondrosarcoma treatment.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression

